Market Overview

The Bioprinting on Organ Transplant Market was valued at US$ 1.05 billion in 2023 and is projected to reach US$ 2.73 billion by 2031, registering a CAGR of 13.2% throughout the forecast period 2024–2031. The Bioprinting on Organ Transplant Market surges with rising organ failure cases and successful transplant outcomes worldwide. In 2023, 46,632 transplants occurred in the US, up 8.7% from 2022, highlighting demand. Technological funding accelerates custom organ creation using bioinks and stem cells.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/bioprinting-on-organ-transplant-market

Market Drivers

Increasing organ transplants drive the Bioprinting on Organ Transplant Market, with 17,000-18,000 annual procedures in India alone, up from 2.43 to 3.05 donors per case since 2016. This addresses global shortages effectively.

R&D funding and advancements in extrusion-based printing enhance precision, reducing rejection risks. These innovations promise personalized organs for better patient matches.

Government support boosts accessibility in high-need regions.

Market Restraints

High costs and side effects restrain the Bioprinting on Organ Transplant Market, with artificial organs demanding significant investment and skilled expertise. Shortages of professionals slow scaling.

Stringent regulations delay approvals, complicating adoption in diverse healthcare systems. These hurdles limit immediate widespread use.

Market Geographical Share

North America holds 42.5% share in the Bioprinting on Organ Transplant Market, led by US advancements and high transplant volumes. Robust funding sustains leadership.

Asia-Pacific grows fastest, with India's rising procedures and China's investments. Europe focuses on regulatory harmony, while South America and Middle East & Africa build foundational capabilities.

Market Segments

By Process

  • Inkjet Bioprinting
  • Laser-Assisted Bioprinting
  • Extrusion-Based Bioprinting
  • Acoustic Bioprinting
  • Magnetic Bioprinting
  • Vatphotopolymerization-based bioprinting
  • Others

By Bioink

  • PEG diacrylate
  • Nanocellulose
  • Collagen I
  • Graphene
  • Others

By Cell Type Used

  • iPS Cells
  • Mesenchymal Stem Cells
  • Keratinocytes
  • Neural Stem Cell
  • Others

By End-User

  • Hospitals
  • Research and Educational Institutions
  • Specialty Clinics
  • Organ Transplantation Centers
  • Others

Market Key Players

3D Systems Corporation, Protolabs, Materialise, Stratasys, General Electric Company, Desktop Metal Inc., Aspect Biosystems Ltd., EnvisionTEC Llc., Ibio Inc., Printivo.

Latest Developments

In November 2023, Cellink and Ossiform partnered to commercialize a ready-to-print bioink, with sales starting in 2024 via Cellink channels.

In October 2023, Carcinotech and CELLINK collaborated on 3D bio-printed tumor models using BIO CELLX for cancer drug development.

In September 2022, 3D Systems formed Systemic Bio for bioprinting in pharmaceutical discovery.

About DataM Intelligence 4Market Research

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market, by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

Key Highlights of Report

Market Growth: The Bioprinting on Organ Transplant Market anticipates a CAGR of 13.2% through 2031, fueled by transplant needs.

North America Dominance: 42.5% share from advanced tech and funding.

Extrusion-Based Leads: Holds 47.8% with regulatory support.

R&D Surge: Partnerships accelerate bioink commercialization.

Cell Innovation: iPS cells enable personalized printing.

COVID-19 Impact: Pandemic shortages spurred bioprinting urgency.

Conclusion

The Bioprinting on Organ Transplant Market ends with transformative promise, revolutionizing access to vital organs globally.